Ticker Scorecard - ADCT Basics Company: ADC Therapeutics SA IPO Date: May 18, 2020 Sector: Healthcare Industry: Biotech Market Cap: $196.28M Activated in VL: True Average Daily Range Avg Daily Range: $0.43 | 3.82% Avg Daily Range (30 D): $0.15 | 6.61% Avg Daily Range (90 D): $0.11 | 4.55% Institutional Daily Volume Avg Daily Volume: .39M Avg Daily Volume (30 D): 1.18M Avg Daily Volume (90 D): .61M Trade Size Avg Trade Size (Sh.): 142 Avg Trade Size (Sh.) (30 D): 181 Avg Trade Size (Sh.) (90 D): 156 Institutional Trades Total Inst.Trades: 286 Avg Inst. Trade: $1.34M Avg Inst. Trade (30 D): $1.03M Avg Inst. Trade (90 D): $1.43M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.39M Avg Closing Trade (30 D): $.92M Avg Closing Trade (90 D): $1.72M Avg Closing Volume: 503.58K     News Oct 31, 2024 @ 4:57 PM Cancer Antibody Drug Conjugates Market, Drugs Appr... Source: Researchandmarkets.Com Aug 6, 2024 @ 10:51 PM ADC Therapeutics berichtet über Finanzergebniss... Source: Adc Therapeutics Jul 12, 2024 @ 10:40 AM Antibody Drug Conjugates Market Insights 2018-2023... Source: Researchandmarkets.Com Jul 2, 2024 @ 4:27 PM ADC Therapeutics gewährt neuen Mitarbeitern Zut... Source: ADC Therapeutics SA Jun 27, 2024 @ 4:23 PM ADC Therapeutics tritt demnächst den Indizes Ru... Source: ADC Therapeutics SA Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.4 $-.42 $-.38 Diluted EPS $-2.4 $-.42 $-.38 Revenue $ 70.72M $ 18.46M $ 17.41M Gross Profit $ $ $ Net Income / Loss $ -212.15M $ -43.97M $ -36.54M Operating Income / Loss $ -138.2M $ -35.56M $ -29.04M Cost of Revenue $ $ $ Net Cash Flow $ -36.14M $ -25.85M $ 65.83M PE Ratio     Splits May 10, 2005:   7:1